# DMT310-009 Topical in the Treatment of Acne Vulgaris

> **NCT06090721** · PHASE3 · COMPLETED · sponsor: **Dermata Therapeutics** · enrollment: 520 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** DMT310
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06090721
- **Lead sponsor:** Dermata Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-08
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-04-30
- **Target enrollment:** 520 (ACTUAL)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06090721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06090721, "DMT310-009 Topical in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06090721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*